Publications by authors named "Anna Capelli"

Claim this Profile
D
Discovery of CHF-6523, an Inhaled Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease.
Paolo Bruno, Daniele Pala, Alessandra Micoli, Mauro Corsi, Alessandro Accetta, Anna Maria Capelli

J Med Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary Fibrosis.
Marta Giuliani, Andrea Rizzi, Mafalda Pagano, Luca F Raveglia, Francesca Saccani, Anna Maria Capelli

ACS Med Chem Lett· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Activity of a Novel Series of Pyridazine-Based ALK5 Inhibitors.
Daniele Pala, Paolo Ronchi, Donatella Rescigno, Barbara Bertani, Anna Maria Capelli

ACS Med Chem Lett· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Optimization of Pyridazinones as PI3Kδ Selective Inhibitors for Administration by Inhalation.
Paolo Bruno, Alessandra Micoli, Mauro Corsi, Daniele Pala, Sara Guariento, Anna Maria Capelli

J Med Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of an "inhalation by design" approach to the identification and in-vitro evaluation of novel purine based PI3Kδ inhibitors.
Roberta Mazzucato, Marinella Roberti, Anna Maria Capelli, Fabio Rancati, Matteo Biagetti

Eur J Med Chem· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders.
Elisabetta Armani, Andrea Rizzi, Nicolò Iotti, Francesca Saccani, Maria Rosaria Di Lascia, Anna Maria Capelli

J Med Chem· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases.
Eleonora Ghidini, Gessica Marchini, Anna Maria Capelli, Chiara Carnini, Valentina Cenacchi

J Med Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs.
Alessio Lodola, Serena Bertolini, Matteo Biagetti, Silvia Capacchi, Fabrizio Facchinetti, Anna Maria Capelli

J Med Chem· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8.
Donatella Callegari, Alessio Lodola, Daniele Pala, Silvia Rivara, Marco Mor, Anna Maria Capelli

J Chem Inf Model· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8.
Donatella Callegari, Alessio Lodola, Daniele Pala, Silvia Rivara, Marco Mor, Anna Maria Capelli

J Chem Inf Model· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLIMPSED: An Improved Docking Protocol for Cognate Docking.
Andrea Rizzi, Andrea Ciacci, Anna Maria Capelli

Mol Inform· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unbinding pathways of VEGFR2 inhibitors revealed by steered molecular dynamics.
Anna Maria Capelli, Gabriele Costantino

J Chem Inf Model· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unbinding pathways from the glucocorticoid receptor shed light on the reduced sensitivity of glucocorticoid ligands to a naturally occurring, clinically relevant mutant receptor.
Anna Maria Capelli, Agostino Bruno, Antonio Entrena Guadix, Gabriele Costantino

J Med Chem· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple monoamine uptake inhibitors.
Anna Maria Capelli, Fabrizio Micheli

Pharm Pat Anal· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
Elisabetta Perdona', Vivian J A Costantini, Michela Tessari, Prisca Martinelli, Corrado Carignani, Anna Maria Capelli

Neuropharmacology· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activity of a novel class nicotinic acetylcholine receptors (nAChRs) ligands structurally related to anatoxin-a.
Daniele Simoni, Riccardo Rondanin, Paolo Marchetti, Cinzia Rullo, Riccardo Baruchello, Anna Maria Capelli

Bioorg Med Chem Lett· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists.
Anna Maria Capelli, Laura Castelletti, Yu Hua Chen, Harjeet Van der Keyl, Luca Pucci

Br J Pharmacol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
Ezio Bettini, Anna Sava, Cristiana Griffante, Corrado Carignani, Alberto Buson, Anna Maria Capelli

J Pharmacol Exp Ther· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological characterization of 5-phenyl-2-[2-(1-piperidinylcarbonyl)phenyl]-2,3-dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones: a new class of Neuropeptide S antagonists.
Fabrizio Micheli, Romano Di Fabio, Angelo Giacometti, Adelheid Roth, Elisa Moro, Anna Maria Capelli

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists.
Fabrizio Micheli, Luca Arista, Barbara Bertani, Simone Braggio, Anna Maria Capelli

J Med Chem· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel alpha7 nAChR positive allosteric modulators with the use of pharmacophore in silico screening methods.
Anna Maria Capelli, Laura Castelletti, Cristian Salvagno, Beatrice Oliosi, Elisa Di Lenarda

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triazolyl azabicyclo[3.1.0]hexanes: A class of potent and selective dopamine D(3) receptor antagonists.
Giorgio Bonanomi, Simone Braggio, Anna Maria Capelli, Anna Checchia, Romano Di Fabio

ChemMedChem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.
Fabrizio Micheli, Luca Arista, Giorgio Bonanomi, Frank E Blaney, Simone Braggio, Anna Maria Capelli

J Med Chem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK(1) receptor antagonists.
Fabio M Sabbatini, Romano Di Fabio, Cristiana Griffante, Giorgio Pentassuglia, Laura Zonzini, Anna M Capelli

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological characterization of novel druglike corticotropin-releasing factor 1 antagonists.
Romano Di Fabio, Yves St-Denis, Fabio M Sabbatini, Daniele Andreotti, Roberto Arban, Anna M Capelli

J Med Chem· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis